Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
Saved in:
| Title: | Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies. |
|---|---|
| Authors: | Song HW; National Institutes of Health, Clinical Center, Center for Cellular Engineering, Bethesda, USA., Somerville RP; National Institutes of Health, Clinical Center, Center for Cellular Engineering, Bethesda, USA., Stroncek DF; National Institutes of Health, Clinical Center, Center for Cellular Engineering, Bethesda, USA., Highfill SL; National Institutes of Health, Clinical Center, Center for Cellular Engineering, Bethesda, USA. |
| Source: | International reviews of immunology [Int Rev Immunol] 2022; Vol. 41 (6), pp. 638-648. Date of Electronic Publication: 2022 Apr 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8712260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1563-5244 (Electronic) Linking ISSN: 08830185 NLM ISO Abbreviation: Int Rev Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1563-5244 |
|---|---|
| DOI: | 10.1080/08830185.2022.2067154 |
